Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Apr-19 5:14 PM View:  | Paya Carlos V President and CEO Director | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 35,576 | $5.85 | $208,120.00 | (100%) 35.58K to 0 | 0% |
| 04-Apr-19 5:15 PM View: | Brady Stephen R EVP, Strategy & Finance | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 17,063 | $5.85 | $99,818.50 | (100%) 17.06K to 0 | 0% |
| 04-Apr-19 5:17 PM View: | Baltimore David Director | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 78,287 | $5.85 | $457,979.00 | (100%) 78.29K to 0 | 0% |
| 04-Apr-19 5:13 PM View: | Ter Meulen Jan Henrik Chief Scientific Officer | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 14,620 | $5.85 | $85,527.00 | (100%) 14.62K to 0 | 0% |
| 02-Apr-19 8:57 PM View: | Column Group L P 10% Owner | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition (change in control) | 6,642,940 | $5.85 | $38,861,200.00 | (100%) 6.64M to 0 | 0% |
| 04-Apr-19 5:14 PM View: | Gombotz Wayne Chief Development Officer | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 37,068 | -- | -- | (100%) 37.07K to 0 | |
| 04-Apr-19 5:06 PM View: | Coleman Lewis W Director | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 178,000 | $5.85 | $1,041,300.00 | (100%) 178.0K to 0 | 0% |
| 04-Apr-19 5:16 PM View: | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 6,136 | $5.85 | $35,895.60 | (100%) 6.14K to 0 | 0% |
| 04-Apr-19 5:24 PM View: | Berger Franklin M Director | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 75,000 | $5.85 | $438,750.00 | (100%) 75.0K to 0 | 0% |
| 07-Jan-19 8:36 PM View: | Paya Carlos V President and CEO Director | Immune Design Corp. (IMDZ) | 07-Jan-19 | Market Sale (Planned) | 13,014 | $1.58 | $20,590.80 | (8%) 169.59K to 156.58K | 9% |
| 07-Jan-19 8:35 PM View: | Ter Meulen Jan Henrik Chief Scientific Officer | Immune Design Corp. (IMDZ) | 07-Jan-19 | Market Sale (Planned) | 3,414 | $1.59 | $5,414.60 | (4%) 87.4K to 83.98K | 9% |
| 07-Jan-19 8:33 PM View: | Brady Stephen R EVP, Strategy & Finance | Immune Design Corp. (IMDZ) | 07-Jan-19 | Market Sale (Planned) | 5,516 | $1.58 | $8,721.90 | (5%) 102.11K to 96.6K | 9% |
| 07-Jan-19 8:34 PM View: | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | Immune Design Corp. (IMDZ) | 07-Jan-19 | Market Sale (Planned) | 3,522 | $1.57 | $5,535.53 | (4%) 82.28K to 78.76K | 8% |
| 07-Jan-19 8:34 PM View: | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | Immune Design Corp. (IMDZ) | 03-Jan-19 | Grant | 25,000 | -- | -- | 44% 57.28K to 82.28K | |
| 07-Jan-19 8:36 PM View: | Paya Carlos V President and CEO Director | Immune Design Corp. (IMDZ) | 03-Jan-19 | Grant | 63,000 | -- | -- | 59% 106.59K to 169.59K | |
| 07-Jan-19 8:33 PM View: | Brady Stephen R EVP, Strategy & Finance | Immune Design Corp. (IMDZ) | 03-Jan-19 | Grant | 25,000 | -- | -- | 32% 77.11K to 102.11K | |
| 07-Jan-19 8:35 PM View: | Ter Meulen Jan Henrik Chief Scientific Officer | Immune Design Corp. (IMDZ) | 03-Jan-19 | Grant | 25,000 | -- | -- | 40% 62.4K to 87.4K | |
| 04-Dec-18 9:59 PM View: | Bvf Partners L P/il 10% Owner | Immune Design Corp. (IMDZ) | 04-Dec-18 | Market Sale | 902,000 | $1.83 | $1,653,910.00 | (16%) 5.72M to 4.82M | 21% |
| 09-Nov-18 4:13 PM View: | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | Immune Design Corp. (IMDZ) | 07-Nov-18 | Grant | 29,953 | -- | -- | 110% 27.32K to 57.28K | |
| 09-Nov-18 4:14 PM View: | Brady Stephen R EVP, Strategy & Finance | Immune Design Corp. (IMDZ) | 07-Nov-18 | Grant | 29,953 | -- | -- | 64% 47.16K to 77.11K | |
| 09-Nov-18 4:15 PM View: | Ter Meulen Jan Henrik Chief Scientific Officer | Immune Design Corp. (IMDZ) | 07-Nov-18 | Grant | 23,362 | -- | -- | 60% 39.03K to 62.4K | |
| 08-Jan-18 8:24 PM View: | Gombotz Wayne Chief Development Officer | Immune Design Corp. (IMDZ) | 05-Jan-18 | Market Sale (Planned) | 1,986 | $4.17 | $8,281.82 | (5%) 39.05K to 37.07K | 65% |
| 08-Jan-18 8:18 PM View: | Brady Stephen R EVP, Strategy & Finance | Immune Design Corp. (IMDZ) | 05-Jan-18 | Market Sale (Planned) | 3,328 | $4.17 | $13,884.70 | (7%) 50.49K to 47.16K | 65% |
| 08-Jan-18 8:21 PM View: | Paya Carlos V President and CEO Director | Immune Design Corp. (IMDZ) | 05-Jan-18 | Market Sale (Planned) | 7,970 | $4.17 | $33,246.90 | (7%) 114.56K to 106.59K | 65% |
| 08-Jan-18 8:19 PM View: | Ter Meulen Jan Henrik Chief Scientific Officer | Immune Design Corp. (IMDZ) | 05-Jan-18 | Market Sale (Planned) | 1,986 | $4.17 | $8,281.62 | (5%) 41.02K to 39.03K | 65% |
| 08-Jan-18 8:24 PM View: | Gombotz Wayne Chief Development Officer | Immune Design Corp. (IMDZ) | 04-Jan-18 | Grant | 16,000 | -- | -- | 69% 23.05K to 39.05K | |
| 08-Jan-18 8:18 PM View: | Brady Stephen R EVP, Strategy & Finance | Immune Design Corp. (IMDZ) | 04-Jan-18 | Grant | 20,000 | -- | -- | 66% 30.49K to 50.49K | |
| 08-Jan-18 8:19 PM View: | Ter Meulen Jan Henrik Chief Scientific Officer | Immune Design Corp. (IMDZ) | 04-Jan-18 | Grant | 18,000 | -- | -- | 78% 23.02K to 41.02K | |
| 05-Jan-18 6:30 PM View: | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | Immune Design Corp. (IMDZ) | 04-Jan-18 | Market Sale | 675 | $4.17 | $2,816.44 | (2%) 28.0K to 27.32K | 65% |
| 08-Jan-18 8:21 PM View: | Paya Carlos V President and CEO Director | Immune Design Corp. (IMDZ) | 04-Jan-18 | Grant | 46,500 | -- | -- | 68% 68.06K to 114.56K | |
| 05-Jan-18 6:30 PM View: | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | Immune Design Corp. (IMDZ) | 04-Jan-18 | Grant | 22,000 | -- | -- | 367% 6.0K to 28.0K | |
| 06-Nov-17 9:15 AM View: | Coleman Lewis W Director | Immune Design Corp. (IMDZ) | 02-Nov-17 | Market Purchase | 50,000 | $4.50 | $225,000.00 | 39% 128.0K to 178.0K | (68%) |
| 01-Nov-17 6:10 PM View: | Berger Franklin M Director | Immune Design Corp. (IMDZ) | 30-Oct-17 | Market Purchase | 25,000 | $4.57 | $114,375.00 | 50% 50.0K to 75.0K | (68%) |
| 27-Oct-17 7:40 PM View: | Svennilson Peter Director 10% Owner | Immune Design Corp. (IMDZ) | 27-Oct-17 | Market Purchase Duplicate | 2,681,000 | $4.10 | $10,992,100.00 | 68% 3.96M to 6.64M | (65%) |
| 31-Oct-17 7:00 PM View: | Coleman Lewis W Director | Immune Design Corp. (IMDZ) | 27-Oct-17 | Market Purchase | 65,000 | $4.07 | $264,752.00 | 103% 63.0K to 128.0K | (64%) |
| 30-Oct-17 5:03 PM View: | Column Group L P 10% Owner | Immune Design Corp. (IMDZ) | 27-Oct-17 | Market Purchase | 2,681,000 | $4.10 | $10,992,100.00 | 68% 3.96M to 6.64M | (65%) |
| 26-Oct-17 7:31 PM View: | Berger Franklin M Director | Immune Design Corp. (IMDZ) | 25-Oct-17 | Market Purchase | 25,000 | $4.26 | $106,620.00 | 100% 25.0K to 50.0K | (66%) |
| 03-Aug-17 5:06 PM View: | Gombotz Wayne Chief Development Officer | Immune Design Corp. (IMDZ) | 01-Aug-17 | Option Exercise | 10,000 | $1.31 | $13,100.00 | 43% 23.05K to 33.05K | |
| 03-Aug-17 5:06 PM View: | Gombotz Wayne Chief Development Officer | Immune Design Corp. (IMDZ) | 01-Aug-17 | Market Option Sale (Planned) | 10,000 | $11.43 | $114,336.00 | (30%) 33.05K to 23.05K | 87% |
| 12-Jul-17 6:08 PM View: | Coleman Lewis W Director | Immune Design Corp. (IMDZ) | 11-Jul-17 | Market Purchase | 2,000 | $9.32 | $18,650.00 | 3% 61.0K to 63.0K | (84%) |
| 12-Jul-17 6:08 PM View: | Coleman Lewis W Director | Immune Design Corp. (IMDZ) | 10-Jul-17 | Market Purchase | 10,000 | $8.99 | $89,950.00 | 20% 51.0K to 61.0K | (84%) |
| 10-Jul-17 7:03 PM View: | Coleman Lewis W Director | Immune Design Corp. (IMDZ) | 07-Jul-17 | Market Purchase | 4,000 | $9.15 | $36,600.00 | 9% 47.0K to 51.0K | (84%) |
| 10-Jul-17 7:03 PM View: | Coleman Lewis W Director | Immune Design Corp. (IMDZ) | 06-Jul-17 | Market Purchase | 4,000 | $9.39 | $37,550.00 | 9% 43.0K to 47.0K | (85%) |
| 22-May-17 7:40 PM View: | Guthart Leo 10% Owner | Immune Design Corp. (IMDZ) | 10-May-17 | Market Purchase | 5,000 | $6.14 | $30,700.00 | < 1% 3.12M to 3.13M | (76%) |
| 22-May-17 7:40 PM View: | Guthart Leo 10% Owner | Immune Design Corp. (IMDZ) | 09-May-17 | Market Purchase | 25,000 | $6.08 | $151,906.00 | < 1% 3.1M to 3.12M | (76%) |
| 06-Jan-17 9:32 PM View: | Paya Carlos V President and CEO Director | Immune Design Corp. (IMDZ) | 04-Jan-17 | Grant | 36,000 | -- | -- | 100% 36.0K to 72.0K | |
| 06-Jan-17 9:32 PM View: | Paya Carlos V President and CEO Director | Immune Design Corp. (IMDZ) | 04-Jan-17 | Market Sale (Planned) | 3,940 | $5.35 | $21,079.00 | (5%) 72.0K to 68.06K | 73% |
| 06-Jan-17 9:35 PM View: | Gombotz Wayne Chief Development Officer | Immune Design Corp. (IMDZ) | 04-Jan-17 | Market Sale (Planned) | 980 | $5.35 | $5,243.00 | (4%) 24.03K to 23.05K | 73% |
| 06-Jan-17 8:51 PM View: | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | Immune Design Corp. (IMDZ) | 04-Jan-17 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 06-Jan-17 9:36 PM View: | Ter Meulen Jan Henrik Chief Scientific Officer | Immune Design Corp. (IMDZ) | 04-Jan-17 | Market Sale (Planned) | 980 | $5.35 | $5,243.00 | (4%) 24.0K to 23.02K | 73% |
